Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
China
Biotech
Geopolitics threatens Chinese biotechs' hot out-licensing biz
For the first time, China biotechs out-licensed more assets in 2023 than they in-licensed.
Max Bayer
Apr 11, 2024 4:00am
BD ups production as FDA warns against syringes from China
Mar 25, 2024 12:15pm
Innovent's Tepezza rival closer to China nod after phase 3 win
Feb 20, 2024 8:38am
I-Mab sheds China footprint to transform into US-based biotech
Feb 7, 2024 8:50am
Arrivent unveils $135M IPO pricing to get furmonertinib to FDA
Jan 22, 2024 10:28am
Windtree hands over more licensing rights to Lee’s Pharma
Jan 17, 2024 9:29am